ARCHIVES

“Miracle-Gro for Cancer?” ODAC Members Vent At Amgen And J&J Over Claims, Advertising.

This article is from The Cancer Letter archive.

Vol. 33 No. 19 | May 18, 2007

Download PDF Visit The Full Archive

Related Articles

Young Investigators Hold Their Own

September 28, 1979

Cancer Panel To Examine Health Of Phase I Trials

May 17, 1996

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

April 2, 1999

DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported

November 17, 1978

Doctors Are Doing More Cancer Screening, ACS Survey Finds

March 30, 1990